November 29, 2012 - Dr. Sandra Dunn's team at UBC department of paediatrics simultaneously publishes data that corresponds with $2.5 million grant winning research at Swedish Medical Center identifying Disulfaram as having potential for brain cancer treatment.
Exploring Alcoholism Drug’s Potential Against Brain Tumors
Previous
Previous
Groundbreaking research in triple-negative breast cancer provides hope
Next
Next